Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Tuberculosis

Free Subscription Articles published in Emerg Infect Dis Retrieve available abstracts of 62 articles: HTML format Text format

Single Articles

March 2018
1. NGUYEN DT, Teeter LD, Graves J, Graviss EA, et al
   Characteristics Associated with Negative Interferon-gamma Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013-2015.
   Emerg Infect Dis. 2018;24:534-540.
   PubMed     Text format     Abstract available
   
   
   
2. CHERNYAEVA E, Rotkevich M, Krasheninnikova K, Yurchenko A, et al
   Whole-Genome Analysis of Mycobacterium tuberculosis from Patients with Tuberculous Spondylitis, Russia.
   Emerg Infect Dis. 2018;24:579-583.
   PubMed     Text format     Abstract available
   
   
   
3. ALTHOMSONS SP, Hill AN, Harrist AV, France AM, et al
   Statistical Method to Detect Tuberculosis Outbreaks among Endemic Clusters in a Low-Incidence Setting.
   Emerg Infect Dis. 2018;24:573-575.
   PubMed     Text format     Abstract available
   
   
   
4. RANDO-SEGURA A, Aznar ML, Moreno MM, Espasa M, et al
   Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.
   Emerg Infect Dis. 2018;24:569-572.
   PubMed     Text format     Abstract available
   
   
   
5. BRENT AJ, Nyundo C, Langat J, Mulunda C, et al
   Prospective Observational Study of Incidence and Preventable Burden of Childhood Tuberculosis, Kenya.
   Emerg Infect Dis. 2018;24:514-523.
   PubMed     Text format    
   
   
   
6. NAIK PR, Moonan PK, Nirgude AS, Shewade HD, et al
   Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India.
   Emerg Infect Dis. 2018;24:478-484.
   PubMed     Text format     Abstract available
   
   
   
7. YEN YF, Pan SW, Su VY, Chuang PH, et al
   Influenza Vaccination and Incident Tuberculosis among Elderly Persons, Taiwan(1).
   Emerg Infect Dis. 2018;24:498-505.
   PubMed     Text format     Abstract available
   
   
   November 2017
8. NATHAVITHARANA RR, Shi CX, Chindelevitch L, Calderon R, et al
   Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru.
   Emerg Infect Dis. 2017;23:1887-1890.
   PubMed     Text format     Abstract available
   
   
   
9. TAO NN, He XC, Zhang XX, Liu Y, et al
   Drug-Resistant Tuberculosis among Children, China, 2006-2015.
   Emerg Infect Dis. 2017;23:1800-1805.
   PubMed     Text format     Abstract available
   
   
   October 2017
10. ACHAR J, Hewison C, Cavalheiro AP, Skrahina A, et al
    Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available
    
    
    
11. MARYANDYSHEV A, Pontali E, Tiberi S, Akkerman O, et al
    Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available
    
    
    
12. JASPARD M, Elefant-Amoura E, Melonio I, De Montgolfier I, et al
    Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available
    
    
    March 2017
13. SETO J, Wada T, Suzuki Y, Ikeda T, et al
    Mycobacterium tuberculosis Transmission among Elderly Persons, Yamagata Prefecture, Japan, 2009-2015.
    Emerg Infect Dis. 2017;23:448-455.
    PubMed     Text format     Abstract available
    
    
    
14. MALM S, Linguissi LS, Tekwu EM, Vouvoungui JC, et al
    New Mycobacterium tuberculosis Complex Sublineage, Brazzaville, Congo.
    Emerg Infect Dis. 2017;23:423-429.
    PubMed     Text format     Abstract available
    
    
    
15. ADJEMIAN J, Frankland TB, Daida YG, Honda JR, et al
    Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA.
    Emerg Infect Dis. 2017;23:439-447.
    PubMed     Text format     Abstract available
    
    
    
16. SCOTT C, Cavanaugh JS, Silk BJ, Ershova J, et al
    Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis.
    Emerg Infect Dis. 2017;23:456-462.
    PubMed     Text format     Abstract available
    
    
    
17. BOURDILLON PM, Goncalves CC, Pelissari DM, Arakaki-Sanchez D, et al
    Increase in Tuberculosis Cases among Prisoners, Brazil, 2009-20141.
    Emerg Infect Dis. 2017;23:496-499.
    PubMed     Text format     Abstract available
    
    
    
18. SIMPSON G, Zimmerman R, Shashkina E, Chen L, et al
    Mycobacterium tuberculosis Infection among Asian Elephants in Captivity.
    Emerg Infect Dis. 2017;23:513-516.
    PubMed     Text format     Abstract available
    
    
    
19. CHANDRANAIK BM, Shivashankar BP, Umashankar KS, Nandini P, et al
    Mycobacterium tuberculosis Infection in Free-Roaming Wild Asian Elephant.
    Emerg Infect Dis. 2017;23:555-557.
    PubMed     Text format     Abstract available
    
    
    
20. BENOIT SR, Gregg EW, Jonnalagadda S, Phares CR, et al
    Association of Diabetes and Tuberculosis Disease among US-Bound Adult Refugees, 2009-2014.
    Emerg Infect Dis. 2017;23:543-545.
    PubMed     Text format     Abstract available
    
    
    
21. ALLANA S, Shashkina E, Mathema B, Bablishvili N, et al
    pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia.
    Emerg Infect Dis. 2017;23:491-495.
    PubMed     Text format     Abstract available
    
    
    
22. ZACHARIAH A, Pandiyan J, Madhavilatha GK, Mundayoor S, et al
    Mycobacterium tuberculosis in Wild Asian Elephants, Southern India.
    Emerg Infect Dis. 2017;23:504-506.
    PubMed     Text format     Abstract available
    
    
    
23. MILLER MA, Buss PE, van Helden PD, Parsons SD, et al
    Mycobacterium bovis in a Free-Ranging Black Rhinoceros, Kruger National Park, South Africa, 2016.
    Emerg Infect Dis. 2017;23:557-558.
    PubMed     Text format     Abstract available
    
    
    
24. DAVIDSON JA, Loutet MG, O'Connor C, Kearns C, et al
    Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002-2014.
    Emerg Infect Dis. 2017;23:377-386.
    PubMed     Text format     Abstract available
    
    
    
25. SURIE D, Fane O, Finlay A, Ogopotse M, et al
    Molecular, Spatial, and Field Epidemiology Suggesting TB Transmission in Community, Not Hospital, Gaborone, Botswana.
    Emerg Infect Dis. 2017;23:487-490.
    PubMed     Text format     Abstract available
    
    
    February 2017
26. DENNING DW, Perlin DS, Muldoon EG, Colombo AL, et al
    Delivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic Capabilities.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available
    
    
    December 2016
27. BARASONA JA, Acevedo P, Diez-Delgado I, Queiros J, et al
    Tuberculosis-Associated Death among Adult Wild Boars, Spain, 2009-2014.
    Emerg Infect Dis. 2016;22:2178-2180.
    PubMed     Text format     Abstract available
    
    
    September 2016
28. KVASNOVSKY CL, Cegielski JP, van der Walt ML
    Treatment Outcomes for Patients with Extensively Drug-Resistant Tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available
    
    
    June 2016
29. MOKROUSOV I, Chernyaeva E, Vyazovaya A, Sinkov V, et al
    Next-Generation Sequencing of Mycobacterium tuberculosis.
    Emerg Infect Dis. 2016;22:1127-9.
    PubMed     Text format    
    
    
    March 2016
30. STORY A, Garfein RS, Hayward A, Rusovich V, et al
    Monitoring Therapy Compliance of Tuberculosis Patients by using Video-Enabled Electronic Devices.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available
    
    
    
31. CLAASSENS MM, van Schalkwyk C, Dunbar R, Ayles H, et al
    Patient Diagnostic Rate as Indicator of Tuberculosis Case Detection, South Africa.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available
    
    
    
32. 
    Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009-2014.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available
    
    
    
33. THAPA J, Paudel S, Sadaula A, Shah Y, et al
    Mycobacterium orygis-Associated Tuberculosis in Free-Ranging Rhinoceros, Nepal, 2015.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format    
    
    
    
34. PEZZOLI L, Gounder S, Tamani T, Daulako MR, et al
    Tuberculosis, Fiji, 2002-2013.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available
    
    
    
35. TUPASI TE, Garfin AM, Kurbatova EV, Mangan JM, et al
    Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012-2014.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available
    
    
    
36. DIERBERG KL, Dorjee K, Salvo F, Cronin WA, et al
    Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available
    
    
    
37. BASAVARAJ A, Chandanwale A, Patil A, Kadam D, et al
    High Tuberculosis Risk among Medical Trainees, Pune, India.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available
    
    
    
38. SULLIVAN T, Ben Amor Y
    Global Introduction of New Multidrug-Resistant Tuberculosis Drugs-Balancing Regulation with Urgent Patient Needs.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available
    
    
    
39. STAGG HR, White PJ, Riekstina V, Cirule A, et al
    Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available
    
    
    
40. PARPIA AS, Ndeffo-Mbah ML, Wenzel NS, Galvani AP, et al
    Effects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa.
    Emerg Infect Dis. 2016;22:433-41.
    PubMed     Text format     Abstract available
    
    
    
41. TSCHAMPL CA, Garnick DW, Zuroweste E, Razavi M, et al
    Use of Transnational Services to Prevent Treatment Interruption in Tuberculosis-Infected Persons Who Leave the United States.
    Emerg Infect Dis. 2016;22:417-25.
    PubMed     Text format     Abstract available
    
    
    
42. SHARMA A, Bloss E, Heilig CM, Click ES, et al
    Tuberculosis Caused by Mycobacterium africanum, United States, 2004-2013.
    Emerg Infect Dis. 2016;22:396-403.
    PubMed     Text format     Abstract available
    
    
    
43. RAJU RM, Raju SM, Zhao Y, Rubin EJ, et al
    Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease.
    Emerg Infect Dis. 2016;22:365-9.
    PubMed     Text format     Abstract available
    
    
    
44. FURIN J, Brigden G, Lessem E, Rich M, et al
    Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available
    
    
    
45. CHORBA T, Breedlove B
    Depictions of Heroism in Battle and Anguish from Tuberculosis.
    Emerg Infect Dis. 2016;22:573-4.
    PubMed     Text format    
    
    
    November 2015
46. ERSHOVA JV, Volchenkov GV, Kaminski DA, Somova TR, et al
    Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia.
    Emerg Infect Dis. 2015;21:2048-51.
    PubMed     Text format     Abstract available
    
    
    
47. ACHAR J, Berry C, Herboczek K, Parpieva N, et al
    Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen.
    Emerg Infect Dis. 2015;21:2105-6.
    PubMed     Text format    
    
    
    
48. PEREZ-LAGO L, Lirola MM, Navarro Y, Herranz M, et al
    Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis.
    Emerg Infect Dis. 2015;21:2098-100.
    PubMed     Text format    
    
    
    
49. KIM JH, Yim JJ
    Achievements in and Challenges of Tuberculosis Control in South Korea.
    Emerg Infect Dis. 2015;21:1913-20.
    PubMed     Text format     Abstract available
    
    
    August 2015
50. DOBLER CC, Korver S, Batbayar O, Nyamdulam B, et al
    Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010-2011.
    Emerg Infect Dis. 2015;21:1451-1454.
    PubMed     Text format     Abstract available
    
    
    
51. LIAO TL, Lin CH, Shen GH, Chang CL, et al
    Risk for Mycobacterial Disease among Patients with Rheumatoid Arthritis, Taiwan, 2001-2011.
    Emerg Infect Dis. 2015;21:1387-95.
    PubMed     Text format     Abstract available
    
    
    June 2015
52. KEMPKER RR, Kipiani M, Mirtskhulava V, Tukvadze N, et al
    Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
    Emerg Infect Dis. 2015;21:992-1001.
    PubMed     Text format     Abstract available
    
    
    
53. SMITH SE, Ershova J, Vlasova N, Nikishova E, et al
    Risk Factors for Acquisition of Drug Resistance during Multidrug-Resistant Tuberculosis Treatment, Arkhangelsk Oblast, Russia, 2005-2010.
    Emerg Infect Dis. 2015;21:1002-11.
    PubMed     Text format     Abstract available
    
    
    
54. KURBATOVA EV, Dalton T, Ershova J, Tupasi T, et al
    Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries.
    Emerg Infect Dis. 2015;21:977-83.
    PubMed     Text format     Abstract available
    
    
    
55. WILLIAMS OM, Abeel T, Casali N, Cohen K, et al
    Fatal nosocomial MDR TB identified through routine genetic analysis and whole-genome sequencing.
    Emerg Infect Dis. 2015;21:1082-4.
    PubMed     Text format    
    
    
    
56. ACOSTA F, Chernyaeva E, Mendoza L, Sambrano D, et al
    Mycobacterium bovis in Panama, 2013.
    Emerg Infect Dis. 2015;21.
    PubMed     Text format     Abstract available
    
    
    March 2015
57. TRIEU L, Proops DC, Ahuja SD
    Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA.
    Emerg Infect Dis. 2015;21:500-3.
    PubMed     Text format     Abstract available
    
    
    
58. CHIU NC, Lin MC, Lin WL, Wang SY, et al
    Mycobacterium bovis BCG-associated osteomyelitis/osteitis, Taiwan.
    Emerg Infect Dis. 2015;21:539-40.
    PubMed     Text format    
    
    
    
59. MUSOKE J, Hlokwe T, Marcotty T, du Plessis BJ, et al
    Spillover of Mycobacterium bovis from wildlife to livestock, South Africa.
    Emerg Infect Dis. 2015;21:448-51.
    PubMed     Text format     Abstract available
    
    
    
60. RAMDAS KE, Lyashchenko KP, Greenwald R, Robbe-Austerman S, et al
    Mycobacterium bovis infection in humans and cats in same household, Texas, USA, 2012.
    Emerg Infect Dis. 2015;21:480-3.
    PubMed     Text format     Abstract available
    
    
    
61. GALLIVAN M, Shah N, Flood J
    Epidemiology of human Mycobacterium bovis disease, California, USA, 2003-2011.
    Emerg Infect Dis. 2015;21:435-43.
    PubMed     Text format     Abstract available
    
    
    
62. THOMAS BS, Okamoto K
    Role of race/ethnicity in pulmonary nontuberculous mycobacterial disease.
    Emerg Infect Dis. 2015;21:544-5.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: